Accessibility Tools

Skip to main content

Featured News

SCHEDULES

  • SCHEDULE OVERVIEW

    Annual Meeting Breakout Schedule

    Posted: 
    PDF version

    SUNDAY, JUNE 1
    7:00 AM 4:00 PM Registration   
    8:00 AM 5:00 PM PRE-COURSE: Diving  
    8:00 AM 5:00 PM PRE-COURSE: Safety: Evaluating equipment for safe use in the hyperbaric environment  
    12:00 PM 1:00 PM Lunch (on own)  
    6:30 PM 8:30 PM Welcome Reception with AsMA  
    MONDAY, JUNE 2
    7:00 AM 4:00 PM Registration   
    8:00 AM 8:45 AM Opening Ceremony / Welcome Announcements / Keynote Introductions with AsMA  
    8:45 AM 10:00 AM Bauer Lecture with AsMA  
    10:00 AM 10:30 AM AsMA-UHMS Exhibits / Break   
    10:30 AM 11:45 AM UHMS Kindwall Keynote with AsMA: Shai Efrati, MD:  The Development of Hyperbaric Medicine from Decompression to Regeneration  
    12:00 PM 2:00 PM Lunch (on own)  
    Session A - HBO2 Theory and Mechanisms  
    2:00 PM 2:30 PM Plenary: International Panel  
    2:30 PM 2:40 PM oral abstract Posters: A B C
    2:40 PM 2:50 PM oral abstract
    2:50 PM 3:00 PM oral abstract
    3:00 PM 3:30 PM Plenary: Session A
    3:30 PM 4:00 PM AsMA-UHMS Exhibits / Break  
    Session B - Clinical HBO2  
    4:00 PM 4:30 PM Plenary: Session B  
    4:30 PM 4:40 PM oral abstract Posters A B C 
    4:40 PM 4:50 PM oral abstract
    4:50 PM 5:00 PM oral abstract
    5:20 AM 5:30 PM Plenary: UHM Fellows: Top articles in Hyperbaric Medicine  
    TUESDAY, JUNE 3
    8:00 AM 4:00 PM Registration   
    8:30 AM 9:00 AM Announcements / Keynote Introductions with AsMA  
    9:00 AM 10:00 AM Reinartz Lecture with AsMA  
    10:00 AM 10:30 AM AsMA-UHMS Exhibits / Break  
    10:30 AM 11:45 AM UHMS Lambertsen Keynote with AsMA:   
    12:00 PM 2:00 PM Lunch (on own)  
    Session C - Decompression Theory and Mechanisms  
    2:00 PM 2:30 PM Plenary: Session C  
    2:30 PM 2:40 PM oral abstract Posters D E F
    2:40 PM 2:50 PM oral abstract
    2:50 PM 3:00 PM oral abstract
    3:00 PM 3:30 PM Plenary:  UHMS STEM Opportunity: Virginie Papadopoulou, PhD  
    3:30 PM 4:00 PM AsMA-UHMS Exhibits / Break  
    Session D - Diving Medicine  
    4:00 PM 4:30 PM Plenary: Session D  
    4:30 PM 4:40 PM oral abstract  
    4:40 PM 4:50 PM oral abstract  
    4:50 PM 5:00 PM oral abstract  
    5:00 PM 5:30 PM Plenary: UHM Fellows: Top articles in Undersea Medicine  
    WEDNESDAY, JUNE 4
    8:00 AM 4:00 PM Registration  
    8:30 AM 10:00 AM  Plenary  
    10:00 AM 10:30 AM AsMA-UHMS Exhibits / Break  
    Session E - HBO2 Operations, Chambers and Equipment  
    10:30 AM 11:00 AM Plenary: Session E  
    11:00 AM 11:10 AM oral abstract  
    11:10 AM 11:20 AM oral abstract  
    11:20 AM 11:30 AM oral abstract  
    11:30 AM 12:00 PM Plenary / orals   
    12:00 PM 2:00 PM Lunch (on own)  
    Session F - Top Case Reports  
    2:00 PM 2:30 PM Plenary: Session F  
    2:30 PM 2:40 PM oral abstract  
    2:40 PM 2:50 PM oral abstract  
    2:50 PM 3:00 PM oral abstract  
    3:00 PM 3:30 PM Plenary / orals   
    3:30 PM 4:00 PM AsMA-UHMS Exhibits / Break   
    4:00 PM 5:30 PM RAM Bowl with AsMA  
    7:00 PM 10:00 PM UHMS honors night  
    THURSDAY, JUNE 5
    8:00 AM 2:00 PM Registration  
    7:30 AM 8:00 AM UHMS Business Meeting  
    8:00 AM 8:15 AM Announcements / Keynote Introductions with AsMA  
    8:15 AM 9:15 AM Armstrong Lecture with AsMA  
    9:15 AM 9:45 AM Break  
    9:45 AM 11:15 AM Hart Keynote (Michael Strauss, MD)  
    11:30 PM 1:30 PM Lunch (on own)  
    ASSOCIATES BREAKOUT SESSION  
    1:30 PM 2:00 PM    
    2:00 PM 2:30 PM    
    2:30 PM 3:00 PM    
    3:00 PM 3:30 PM break  
    3:30 PM 4:00 PM    
    4:00 PM 4:30 PM    
    4:30 PM 5:00 PM    
    6:00 PM 9:00 PM AsMA honors night  
    9:00 PM 12:00 PM AsMA / UHMS after party  

     

    Read more

  • GENERAL SESSION SCHEDULE

    THURSDAY, JUNE 18 - SATURDAY, JUNE 20
    PDF copy
    Subject to change
    Posted 

     

    COMING SOON 

     


     

     

     

    Read more

  • PRE-COURSE SCHEDULES

    PRE-COURSES: WEDNESDAY, JUNE 17

          
    FITNESS TO DIVE

    subject to change: posted: 

    Read more

  • NON-PHYSICIAN TRACK SCHEDULE

    SATURDAY, JUNE 20
    Posted: 
    (not approved for physician CME credits)

    COMING SOON 

     

     

    Read more

  • ABSTRACT SCHEDULE

    ABSTRACT SCHEDULE

    POSTED: 4/10/23

    FRIDAY, JUNE 16
    11:30 AM 12:00 PM Posters: Session A: (A1-A2, A4) & Session B: (B5, B7-B21)

    • A1: Hippocampal neuronal death partially inhibited with early hyperbaric oxygen therapy in asphyxial cardiac arrest rat model: Hyoung Youn Lee, PhD

    • A2: Oxidative burst and cytokine expression in patients and healthy volunteers receiving hyperbaric oxygen: A pilot study: Lindell K. Weaver, MD, FACP, FCCP, FCCM, FUHM
    • A4: Early single-session hyperbaric oxygen therapy attenuates post cardiac arrest renal injury in asphyxial cardiac arrest rat model: YS Lee, MD
    • B5: National outcomes of hyperbaric oxygen in necrotizing soft tissue infections: William Toppen, MD
    • B7: Age and diabetes increase refractive changes over time with hyperbaric oxygen: Jay C. Buckey, M.D.
    • B8: Pilot evaluation of long-term follow-up for the Multicenter Registry for Hyperbaric Oxygen Therapy: Jay C. Buckey, M.D.
    • B9: Multicenter Hyperbaric Outcomes Registry: 2022 review: Jay C. Buckey M.D.
    • B10: Retrospective assessment of the “Duke Mods”, An approach to reducing hyperbaric tender decompression sickness risk for multiplace chamber operations: M. Claire Ellis
    • B11: Association between number of hyperbaric oxygen therapy sessions and neurocognitive outcomes of acute carbon monoxide poisoning: Yong Sung Cha, MD, PhD
    • B12: Utility of echocardiographic global longitudinal strain to predict myocardial fibrosis in patients in carbon monoxide poisoning: Yong Sung Cha, MD, PhD
    • B13: Hyperbaric oxygen therapy regimens, treated conditions, and adverse effect profile: A UHMS survey study:
      Matteo Laspro, BA
    • B14: Perception and availability of hyperbaric oxygen therapy as a treatment modality for carbon monoxide poisoning among emergency medicine physicians: Tyler Connely, BS
    • B15: Early hyperbaric oxygen therapy is associated with favorable outcome in iatrogenic cerebral arterial gas embolism: Individual patient data meta-analysis of observational studies: Robert P. Weenink, CAPT (Navy), MD, PhD
    • B16: Hyperbaric oxygen therapy chamber supervision across the usa: how often do practitioners supervise more than one HBO2 simultaneously?: Helen Gelly, MD, FUHM, UHM/ABPM
    • B17: Inflammatory response profiles in COVID-19 patients treated with hyperbaric oxygen therapy compared with best practice: Anders Kjellberg, MD
    • B18: The objective effects of Hyperbaric oxygen therapy  on the chronic non-healing wounds using digital planimetry:
      Mor Rittblat, MD
    • B19: Severe digital frostbite treated with hyperbaric oxygen therapy: Jessica Hoge, MD
    • B20: Effectiveness of 6-week follow-up after hyperbaric oxygen treatment for carbon monoxide poisoning in identifying delayed neurological sequelae and referral to neurological services: Dallin Lindahl, MD, MS
    • B21: Oxygen concentration in and around a monoplace hyperbaric chamber after emergency decompression and defibrillation safety: Justin P. Meunier, MD
        ORAL PRESENTATIONS
    2:00 PM 2:10 PM B11: Association between number of hyperbaric oxygen therapy sessions and neurocognitive outcomes of acute carbon monoxide poisoning; Yong Sung Cha, MD, PhD
    2:10 PM 2:20 PM B18: The objective effects of Hyperbaric oxygen therapy on the chronic non-healing wounds using digital planimetry;
    Mor Rittblat, MD
    2:20 PM 2:30 PM A3: Sex differences in susceptibility to central nervous system oxygen toxicity: Matthew S. Makowski, MD
    4:30 PM 4:40 PM B5: National outcomes of hyperbaric oxygen in necrotizing soft tissue infections: William Toppen, MD
    4:40 PM 4:50 PM B6: A Randomized Trial of Preoperative Hyperbaric Oxygen (HBOT) Before Pancreaticoduodenectomy: Enrico Camporesi, MD
    4:50 PM 5:00 PM B7: Age and diabetes increase refractive changes over time with hyperbaric oxygen: Jay Buckey, MD
    5:00 PM 5:30 PM Posters: Session B: (B22-B41)
    • B22: U.S. multicenter randomized controlled trial of hyperbaric oxygen for COVID-19 patients with moderate to severe hypoxemia: Enoch Huang, MD, MPH&TM, FUHM
    • B23: Hyperbaric oxygen treatment + icing achieves the effects of icing and thermotherapy simultaneously in a rat acute skeletal muscle contusion model: Takashi Hoshino MD, PhD
    • B24: Dartmouth Registry Annual Report: A look at treatment of conditions outside of UHMS indications:
      Hideaki Leo Tanaka, MD, FACEP
    • B25: Feasibility and FDA evaluation for a Phase II Clinical Trial on efficacy of hyperbaric oxygen therapy for post COVID condition: Hideaki Leo Tanaka, MD, FACEP
    • B26: Risk factors for complications of orthopedic trauma – post hoc analysis of the HOLLT Study data: Ian Millar MBBS
    • B27: Assessing hyperbaric and undersea medicine physicians prescribing practices regarding HBO2 for non-emergent indications in patients who smoke: Kaighley Brett, MD
    • B28: A randomized, double-blind trial of hyperbaric oxygen for persistent symptoms after brain injury (HYBOBI-2):
      Lindell K. Weaver, MD, FACP, FCCP, FCCM, FUHM
    • B29: Carbon monoxide poisoning from being towed behind a boat: Lindell K. Weaver, MD, FACP, FCCP, FCCM, FUHM
    • B30: A 19-year retrospective analysis of hyperbaric oxygen seizures : Geness Koumandakis, RRT
    • B31: Does slow and steady win the race? Consideration on optimal compression time: Samuel Hawkins, MD
    • B32: CO-oximetry in the emergency department: Jeffrey Cooper, MD
    • B33: Hyperbaric oxygen therapy for renal abscess: A case series: Kazuki Yanagida, MD
    • B34: Current trends in hyperbaric oxygen therapy use in central retinal artery occlusion management in US hyperbaric facilities: William Toppen, MD
    • B35: Neuropsychological outcomes in a randomized, double-blind trial of hyperbaric oxygen for persistent symptoms after brain injury: Rosemary Ziemnik, MS
    • B36: Safety and adverse events in a randomized, double-blind trial of hyperbaric oxygen for persistent symptoms after brain injury (HYBOBI-2): Rosemary Ziemnik, MS
    • B37: Hyperbaric treatment improves late effects of radiation on the chest wall: Joan Chou, MD
    • B38: Successful placement and activation of artificial urethral sphincter for urinary incontinence after completing adjunctive hyperbaric oxygen therapy for radiation cystitis: Dallin Lindahl, MD, MS
    • B39: Myodesopsia after hyperbaric oxygen therapy: An unusual case report: Jiho Lee, PhD
    • B40: Hyperbaric oxygen therapy for thalamic pain syndrome: Peter Lennox MD
    • B41: HBO2 for wound in irradiated field leads to avoidance of surgery: A case report: Jayanth Adusumalli, MBBS, MPH
    SATURDAY, JUNE 17
        ORAL PRESENTATIONS
    10:30 AM 10:40 AM C55: Diving into decompression sickness-resistant rat’s gene expression of genes involved in antioxidant mechanisms and mitochondrial biogenesis; Emmanuel Dugrenot, PhD
    10:40 AM 10:50 AM C56: Real-time deployment feasibility of deep learning VGE detection models for ultrasound echocardiograms:
    Arian Azarang, PhD
    10:50 AM 11:00 AM C58: Effects of oxygen prebreathing on tissue nitrogen content under normobaric and hyperbaric conditions:
    Edward Ashworth, PhD
    11:00 AM 11:10 AM C52: Elevations of inflammatory biomarkers in closed circuit SCUBA divers parallel those in DCS models: Stephen Thom, MD
    11:10 AM 11:20 AM C53: A Novel Method for Observing Gaseous Nitrogen In Vivo and Ex Vivo Using Radioactive Nitrogen-13: Edward Ashworth, PhD
    11:20 AM 11:30 AM C54: Preliminary qualitative assessment of bubbles inside porcine lymph nodes, imaged by ultrasound after a provocative dive profile: Josh Currens, BS
    11:30 AM 12:00 PM Posters: Session B: (B42-B51) & Session C: (C54-C62)
    • B42: Use of hyperbaric oxygenation therapy for Cyclophosphamide-Induced Hemorrhagic Cystitis.  A case report with a call for awareness and advocacy: Denise Nemeth, OMS-II, MPAS, PA-C
    • B43: CT perfusion patterns in iatrogenic cerebral arterial gas embolism: a retrospective cohort study: R.A. Fakkert, MD
    • B44: Hyperbaric oxygen therapy for cerebral radiation necrosis secondary to stereotactic radiation: A Case Series:
      Jeffrey Cooper, MD
    • B45: Incidence of COVID-19 history among patients with ISSNHL treated with hyperbaric oxygen therapy:
      Jacek Kot, MD, PhD
    • B46: Hyperbaric oxygen therapy for pyoderma gangrenosum as a new treatment strategy: HOTPANTS trial: Ellen C. Kop, MD, PhD
    • B47: A research on the application of hyperbaric oxygen  treatment for the treatment of sepsis: Xuyuan Kuang, MD, PhD
    • B48: Delayed encephalopathy of tramadol overdoses related CHANTER syndrome successfully treated with consecutive hyperbaric oxygen therapy: Naoto Jingami, MD, PhD
    • B49: Hyperbaric oxygen for long-covid condition: Joshua J. White, JD
    • B50: Why wound you heal?: Liz Eshleman, MSN, FNP-C
    • B51: E-cigarette explosion leading to oropharyngeal cancer: Jessica Coffendaffer, MSN, APRN, FNP-C
    • C54: Preliminary qualitative assessment of bubbles inside porcine lymph nodes, imaged by ultrasound after a provocative dive profile: Josh Currens, BS
    • C55: Diving into decompression sickness-resistant rat’s gene expression of genes involved in antioxidant mechanisms and mitochondrial biogenesis: Emmanuel Dugrenot, PhD
    • C56: Real-time deployment feasibility of deep learning VGE detection models for ultrasound echocardiograms:
      Arian Azarang, PhD
    • C57: Automated grading of venous gas emboli in Doppler ultrasound achieves human inter-rater agreement performance: A log-scale mel spectrogram-based deep learning approach: Arian Azarang, PhD
    • C58: Effects of oxygen prebreathing on tissue nitrogen content under normobaric and hyperbaric conditions:
      Edward Ashworth, PhD
    • C59: A PET compatible hyperbaric chamber for rodents to enable temporal and spatial monitoring of tissue nitrogen gas (nitrogen-13) in vivo: Edward Ashworth, PhD
    • C60: Pathophysiology of cutis marmorata in porcine decompression sickness: Aashay Patel, BSPH
    • C61: Stress and inflammation salivary analytes collected from standardized dives: Rhiannon Brenner
    • C62: Measuring whole-body inert gas turnover: Oscar Plogmark, MD, PhD student
        ORAL PRESENTATIONS
    3:00 PM 3:10 PM D65: Preliminary evidence that fourteen days of apnea and hypoxia exposures reduces circulating pro-inflammatory microparticles: Zachary Schlader, PhD
    3:10 PM 3:20 PM D66: Analysis of chest radiographs from navy SEAL (Sea Air Land) candidates developing pulmonary symptoms while swimming: Two different patterns of what previously has been described as pulmonary: Peter Lindholm, MD, PhD
    3:20 PM 3:30 PM D67: Arterial PCO2 during submersed prone exercise suggests attenuation of hypercapnia after respiratory muscle training: Nicholas Bartlett
    5:00 PM 5:30 PM Posters: Session C: (C63-C64) & Session D: (D68-D83) & Session F: (F117)
    • C63: A quantitative approach to assess similarity between dives under the Bühlmann decompression algorithm constraints: Josh Currens, BS
    • C64: Analysis of gas evolution in the heart, liver and kidney of turtles presenting with decompression sickness based on ultrasonography: Katherine Eltz, BS, PhD Student
    • D68: Effects of hyperbaric exposure on perceptual-motor coordination: Nozomu Kageyama , PhD
    • D69: Nitrous oxide consistently attenuates thermogenic and thermoperceptual responses to repetitive cold stress in humans: Maaike Iris Moes, Msc
    • D70: Relative hypoxemia at depth during breath-hold diving investigated through arterial blood gas analysis and lung ultrasound: Gerardo Bosco, MD, PhD
    • D71: Evaluation and follow-up of divers after COVID-19 infection: A prospective, observational study: Charlotte Sadler, MD
    • D72: Exercise-related drops in blood oxygen saturation to diagnose marginal decompression sickness cases:
      Gabriela Morales, BSE
    • D73: DRACO 2023: DAN looks at increased gas consumption upon return to dive in divers with COVID-19 infection:
      Frauke Tillmans, PhD
    • D74: Divers treated in Townsville, Australia: Worse symptoms lead to poorer outcomes: Denise F Blake, BN, MD, FRCPC, FACEM, PGDipMedSci (DHM), Dip DHM, PhD candidate
    • D75: Cost effectiveness of urinalyses in occupational diver clearance: William Toppen, MD
    • D76: Sampler and proposed biological test for contaminated water at dive sites: Rachel M Lance, PhD
    • D77: Treatment of decompression sickness at Kawashima Orthopaedic Hospital: Masayuki Kawashima, MD
    • D78: Lack of recompression facilities for diving injuries on the Central Gulf Coast: Julio R. Garcia RN, BSN, ACHRN, WCC, FAPWCA
    • D79: Maximal fat oxidation in relation to 20 weeks of military diver training: Clara Sjöblom MSc
    • D80: Identifying low risk dive profiles in the Canadian Diving Data and Doppler Ultrasonic Data BASE: A retrospective review: Kaighley Brett, MD
    • D81: Neurocognitive performance during repetitive recreational harvesting dives: Grant Dong B.S.
    • D82: From UPTD to ESOT: Monitoring hyperoxic exposure in surface-oriented diving: Jan Risberg, MD, PhD
    • D83: State of the art review – Cardiac fitness assessment for diving in individuals with pre-existing asymptomatic coronary artery disease: Weien Chow, MRCP, M.Med
    • F116: Bedside fluorescence microangiography aids decision-making regarding hyperbaric oxygen therapy for a compromised flap: Jenny Thacker, MD, FACEP
    SUNDAY, JUNE 18
        ORAL PRESENTATIONS
    9:00 AM 9:30 AM E100: Rapid discharge of rechargeable lithium-ion batteries at 1ATA and 3ATA: Chae Bliss, CHT
    9:30 AM 9:40 AM E92: GO/NO GO: A tool to eliminate the guesswork in determining which items may be allowed in a hyperbaric chamber:
    Jeff Mize RRT, CHT, UHMSADS
    9:40 AM 9:50 AM E98: A solution for clinical hyperbaric facilities to easily standardize, track and document routine safety inspections: Checklist-based digital task manager: Tiffany Hamm BSN, RN, ACHRN, CWS, UHMSADS
    9:50 AM 10:00 AM F123: Pneumorrhachis and pneumocephalus following epidural anesthesia for labor and delivery: A case report and systematic review: Michelle Cao, BA
    2:30 PM 2:40 PM E88: A Case to Support the Routine Monitoring and Analysis of Breathing Gases Provided to the BIBS Line from Vendor Provided K Cylinder Storage: John Sullivan, CHT
    2:40 PM 2:50 PM E89: Barriers to 24/7 Availability and Emergent Clinical Capabilities of Hyperbaric Medicine Facilities: A Large-Scale Survey Study: John McGlynn, MD
    2:50 PM 3:00 PM E90: Strengths and Weaknesses of Monoplace vs Multiplace Chambers for Hyperbaric Critical Care: Ian Millar, MBBS
    3:30 PM 4:00 PM Posters: Session D: (D84-D87) & Session E: (E88-E97; E99-E101) & Session F: (F102-F103)
    • D84: Redefining work of breathing: Addressing modeling gaps in instantaneous flow models: Victoria Ribeiro Rodrigues, BS, PhD Student
    • D85: Determination of tidal volume-controlled buoyancy boundaries’ impact on diver workload efficiency: Aviad Cahana, BSc
    • D86: Crochetage pattern: An electrocardiographic warning sign for scuba divers: Sarah Crawford MD, MSc
    • D87: Development of a model to simulate underwater physiology: Tobias Cibis, PhD Candiate 
    • E88: A case to support the routine monitoring and analysis of breathing gases provided to the BIBS Line from vendor-provided K cylinder storage: John Sullivan, CHT
    • E89: Barriers to 24/7 availability and emergent clinical capabilities of hyperbaric medicine facilities: A large-scale survey study: John J McGlynn, MD
    • E90: Strengths and weaknesses of monoplace vs multiplace chambers for hyperbaric critical care: Ian Millar, MBBS
    • E91: Allowing emergency decompression for inside attendant during hyperbaric oxygen therapy: Oscar Plogmark, MD, PhD student
    • E93: Laptop-style POCUS machines in the multiplace HBO2 chamber: Jenny Thacker, MD, FACEP
    • E94: The development of hyperbaric medicine in Korea since 2017: Sungmin Lee, MD, PhD
    • E95: Evaluating the function and safety of a Bluetooth™ device in the multiplace hyperbaric environment:
      Andrew Melnyczenko, BSHCA, CHT
    • E96: Evaluation of an elastomeric respirator for use in the multiplace hyperbaric environment: Heather Viste, BAN, RN
    • E97: Effects of airway and pressure threshold resistance on fatigue and cognition in divers: Daniel Steven Williams, BSCPE, MSEE
    • E99: Predicting tidal volume of the Zoll Z Ventilator in a hyperbaric chamber: Abigail Winn, MD
    • E100: Rapid discharge of rechargeable lithium-ion batteries at 1ATA and 3ATA: Chae Bliss BS, CHT, EMT
    • E101: How hard is it to change from lithium-ion to alkaline fuel cell in a portable device?: Tony Turner, MAICD
        ORAL PRESENTATIONS
    4:00 PM 4:10 PM F102: Hyperbaric oxygen therapy in the management of upper extremity frostbite injury: A case series: Olayinka David Ajayi, MD, MPH
    4:10 PM 4:20 PM F103: Fluorescence microangiography as a novel tool to identify and monitor ischemia in crush injury: Margot Samson, MD
    4:20 PM 4:30 PM F104: Acute Central Retinal Artery Occlusion from Cosmetic Filler Injection: Casey Smith, MD
    4:30 PM 5:00 PM Posters: Session F: (F104-F116; F118-F124)
    • F102: Hyperbaric oxygen therapy in the management of upper extremity frostbite injury: A case series:
      Olayinka David Ajayi, MD, MPH
    • F103: Fluorescence microangiography as a novel tool to identify and monitor ischemia in crush injury: Margot Samson, MD
    • F104: Acute central retinal artery occlusion from cosmetic filler injection: Casey Smith, MD
    • F105: New seizure disorders after carbon monoxide poisoning: Lindell K. Weaver, MD, FACP, FCCP, FCCM, FUHM
    • F106: Hyperbaric oxygen treatment for paracentral acute middle maculopathy: A case study: Robert Neiberger, DO
    • F107: Atypical avascular necrosis treated with hyperbaric oxygen therapy: Cheryl Hickey, MD
    • F108: Acute Traumatic Polymicrobial Pinna Perichondritis Treated with Hyperbaric Oxygen Therapy:
      Raymond C. Shields, MD
    • F109: Hyperbaric oxygen therapy in cases of BK virus hemorrhagic cystitis: Christopher Allen, MD
    • F110: Case report of an intractable cough due to radiation pneumonitis treated with hyperbaric oxygen:
      Gerald H. Markovitz, MD
    • F111: Polyarteritis nodosa treated with hyperbaric oxygen therapy: Jessica Hoge, MD
    • F112: Hyperbaric oxygen therapy for the treatment of carbon monoxide-induced delayed neurological sequelae: A case report and review of the literature: Colin Teo, MBBS
    • F113: Successful outcome from persistent brain abscess with addition of adjunctive hyperbaric oxygen therapy:
      Christopher Woodard, MB, BCH, BAO
    • F114: Resolution of ischemic colitis with perforation, with hyperbaric oxygen treatments: Kim Wilkinson, RN-AND
    • F115: Altitude DCS treatment options: Nathan Kwan, MAJ (Army), MD
    • F117: Massive venous gas embolism in a diver post-COVID: Jenny Thacker, MD, FACEP
    • F118: Acute cognitive impaired diver hyperbaric treatment effect: A case series: Ian Kirby, MD, CCFP, UHM
    • F119: Case report of PFO closure in an occupational diver after Type II DCS: Kaighley Brett, MD
    • F120: Immersion pulmonary edema: Not limited to a specific UBA: James E. Breuer, MD
    • F121: Alternate teatment For AGE when USN TT6 not feasible: Shane Day, DO, MPH, MS, CP
    • F122: Good result of hyperbaric oxygen therapy in a 50 year old male with chronic therapy refractair osteomyelits on the left foot, with diabetes mellitus and sensomotoric axonal polyneuropathy: Ellen C. Kop, MD, PhD
    • F123: Pneumorrhachis and pneumocephalus following epidural anesthesia for labor and delivery: A case report and systematic review: Michelle Cao, BA
    • F124: Unusual Presentation of Diplopia and Oxygen Toxicity Symptoms after 100% Oxygen Closed Circuit Rebreather Diving: A Case Report: Chiew Wenqi, MBBS

    Read more